How Stem Cell Treatment Can Help Spinal Cord Injury Patients
STEP 1
Uncomplicate The Condition
Spinal Cord Injury (SCI) is a condition caused by damage or trauma to any region of the spine or the neural tissue, usually leading to a permanent loss of motor, sensory and autonomic function. SCI can be either ‘complete’ or ‘incomplete’ based on the functioning below the level of injury and patients can be classified as either ‘paraplegic’ or ‘quadriplegic’.
STEP 2
Available Treatment Options
The conventional approach for Spinal Cord Injury patients includes rehabilitation therapies like physical therapy and occupational therapy. While these can help patients to better manage their daily living activities, they do not address the underlying issue ie. Spinal Cord Injury. Regenerative therapy using stem cells is increasingly becoming the preferred treatment modality for Spinal Cord Injury patients.
STEP 3
IMPROVE THE QUALITY OF LIFE
Stem cell treatment has the potential to repair and regenerate the damaged and non-functional cells in the spinal cord. Nutech MediWorld's Stem Cell Treatment helps to improve the function of the motor, sensory and autonomic systems in patients with Spinal Cord Injury. The result is improved mobility, better sensory functions and an enhanced quality of life.
- Improved Motor Abilities
- Better Sensory Function
- Improved Autonomic Function
- Improved Bladder Function
- Improved Bowel Function
- Better ASIA Score
Nutech MediWorld's Approach to Spinal Cord Injury Treatment
Nutech MediWorld's Proprietary Technology For Spinal Cord Injury Treatment
Patent Protected Reostem® Technology
We use SCT-N® and SCT-NX® products, based on a proprietary stem cell platform, ReoStem®, which comprises of a unique, replicable, clinical-stage technology for the generation and clinical application of allogenic stem cells.
Universal Applicability
Nutech Mediworld’s regenerative medicine products are universally applicable: they do not require tissue-matching or the co-administration of immunosuppressive drugs.
Highest Standards Of Safety
There is no evidence of teratoma generation or tumorigenesis associated with SCT-N® or SCT-NX® use in over 17 years of clinical practice across thousands of patients.
Cell Scalability & Expansion
The unique cell culture methodology allows scalability of cell expansion and production.